Articles

Genomics – the gateway to personalised medicine

29th July 2014

Genomics – the gateway to personalised medicineSarah Holme

Since the completion of the human genome project in 2003, a world of possibilities has been opened up for the personalisation of medicine. From determining predisposition to disease through to... Read more

Who influences NICE technology appraisals?

28th July 2014

Who influences NICE technology appraisals?Leela Barham

In the world of pharmaceuticals everyone seems to have heard of the National Institute for Health and Care Excellence (NICE). That's not only because of its influence on access to... Read more

Clinical trials insight: oncology

25th July 2014

Clinical trials insight: oncologyNick Kenny

INC Research's Dr Nick Kenny talks to pharmaphorum about the challenges of running global clinical trials in the rapidly evolving field of oncology.What are the biggest challenges in planning oncology... Read more

Building brand loyalty through holistic customer management

24th July 2014

Building brand loyalty through holistic customer managementJenny Cowderoy

Pharma companies are looking at non-related industries with a track record in digital innovation to benchmark their own digital activities, but overall they continue to make slow progress in digital... Read more

News

Transmission-blocking vaccines 'could hold key to malaria control'

29th July 2014

Transmission-blocking vaccines 'could hold key to malaria control'Staff reporter

A vaccine that prevents transmission of the malaria parasite from mosquitoes to people could hold the key to effective, population-wide control of the disease, according to researchers.A team from German... Read more

High uptake for Novartis’ meningitis B vaccination programme

29th July 2014

High uptake for Novartis’ meningitis B vaccination programmeLinda Banks

Novartis' first-in-class meningitis B vaccine Bexsero has seen high uptake for the first regional vaccination programme in the world, which is taking place in Canada.The vaccine is one of the... Read more

Leukaemia drugs move closer to European approval

29th July 2014

Leukaemia drugs move closer to European approvalAndrew McConaghie

Two groundbreaking new treatments for chronic lymphocytic leukaemia have been recommended by Europe's CHMP medicines committee.This means the two drugs, Janssen's Imbruvica (ibrutinib) Gilead's Zydelig (idelalisib) are just one step... Read more

Australian Health Minister's bid to censor CF comments backfires

28th July 2014

Australian Health Minister's bid to censor CF comments backfiresStaff reporter

Australia's Health Minister Peter Dutton may be regretting his decision to remove posts on his Facebook account complaining about access to Vertex' cystic fibrosis drug Kalydeco.Patients and carers for people... Read more

Audio & Video

Webinar: 9 July - The future of UK pharm…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

Rare Disease Day tweetchat

 

To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more

Is there common ground for engagement be…

Doctors net webinar

 

The growth of online networks for doctors has been accompanied by recognition from the pharmaceutical industry that these digital meeting grounds can be... View more

Executive Perspectives: Jane Griffiths

 

In the latest in our series of interviews with senior executives who are steering the global pharma industry through a period of unparalleled change, pharmaphorum... View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

Synthetic biology firm raises $29m

A US company set up to create engineered bacteria that can both detect and treat diseases has raised $29 mill... Read more

News

World Hepatitis Day highlights the positive

The push to raise awareness of hepatitis globally has been boosted by recent debate around Gilead's breakthrough... Read more

News

AstraZeneca to collaborate on DNA diagnostics for cancer

AstraZeneca is to collaborate on two new diagnostics which would allow doctors to screen for lung cancer simp... Read more

News

Alcon's Simbrinza approved in EU for glaucoma

Alcon's Simbrinza eye drops suspension has been approved by the EC to decrease elevated intraocular pressure (IO... Read more

News

NICE recommends new breast cancer radiotherapy

An innovative new type of radiotherapy for breast cancer is set to be recommended for NHS patients in England un... Read more

News

GSK struggles to maintain respiratory dominance

Something seems to be going awry with GlaxoSmithKline's game plan for its respiratory franchise, with new pro... Read more

News